![](/img/cover-not-exists.png)
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Chang, Ming-Kang, Kramer, Ina, Huber, Thomas, Kinzel, Bernd, Guth-Gundel, Sabine, Leupin, Olivier, Kneissel, MichaelaVolume:
111
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.1413828111
Date:
December, 2014
File:
PDF, 1.46 MB
english, 2014